Please ensure Javascript is enabled for purposes of website accessibility

Why Aurora Cannabis, Hexo, and Aphria Stocks Are On Fire Today

By Rich Smith - Updated Apr 28, 2021 at 2:25PM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Marijuana stocks light up on renewed interest from Bank of America.

What happened

Marijuana stocks are lighting up in Wednesday afternoon trading, with shares of Aurora Cannabis (ACB 2.27%) and Aphria (APHA) both gaining 4.8% through 1 p.m. EDT, and Hexo (HEXO 0.67%) surging more than twice as much, up 11%.

You can thank Bank of America for that.

Marijuana plants

Image source: Getty Images.

So what

Early this morning, Bank of America resumed coverage on a trio of the best-known marijuana stocks: Aurora Cannabis (which is up today), Tilray (TLRY) (which is merging with Aphria, sending that stock up), and Canopy Growth (CGC -1.40%).

Curiously, BofA was most positive about Canopy's chances, resuming coverage of the stock with a buy rating and a prediction that the stock will hit $36 a share within a year -- a 28.5% gain from its current stock price of about $28. As StreetInsider.com reported today, BofA thinks that Canopy's "balance sheet, mgmt team and partnerships position CGC well to enter the US if there is federal legalization ... [and that] CGC's improving EBITDA and cash flow make its shares attractive in the meantime."

But BofA feels broadly positive about the rest of the marijuana industry as well, sparking a stock price rally across the sector. As TheFly.com just reported, BofA believes the United States is on track toward legalizing marijuana use at the federal level (a thesis I agree with, by the way), although the timeline for such legalization still remains uncertain.

Now what

Given the uncertainty about timing, however, investors might want to give special consideration to some of the reservations Bank of America expressed, despite its broad optimism about the marijuana industry.

In particular, the analyst highlights Tilray's low cash balance (the company actually carries more debt than it has cash available to pay it with) as a concern, as well as its "lack of a major CPG investment partner," notes TheFly. Aurora Cannabis is in a similar position, debt-wise, which probably explains why, out of the three stocks on which Bank of America resumed coverage today, Aurora was the only one tagged with a rating lower than buy.

Even if Aurora, Aphria, and Hexo are the stocks gaining the most from Bank of America's comments today, Canopy Growth is still the marijuana stock Bank of America likes best.

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

Aurora Cannabis Stock Quote
Aurora Cannabis
ACB
$1.35 (2.27%) $0.03
Canopy Growth Stock Quote
Canopy Growth
CGC
$2.81 (-1.40%) $0.04
HEXO Stock Quote
HEXO
HEXO
$0.21 (0.67%) $0.00
Tilray Stock Quote
Tilray
TLRY
Aphria Stock Quote
Aphria
APHA

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning analyst team.

Stock Advisor Returns
311%
 
S&P 500 Returns
110%

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 07/02/2022.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.